Cartesian Therapeutics, Inc. Detailed Financials
Full historical quarterly statements
| Metric | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 78K | 947K | 452K | 298K | 1.1M | -759K | 387K | 33.4M |
| Cost of Goods Sold | 0 | 0 | 12.8M | 0 | 0 | 0 | 0 | 0 |
| Gross Profit | 78K | 947K | -12.3M | 298K | 1.1M | -759K | 387K | 33.4M |
| R&D Expenses | 19.5M | 14.7M | 13.8M | 14.9M | 14.7M | 11.3M | 11.4M | 12.7M |
| Operating Expenses | 26.6M | 22.9M | 8.7M | 22.1M | 23.0M | 26.0M | 18.0M | 19.7M |
| Operating Income | -26.5M | -21.9M | -21.1M | -21.8M | -21.9M | -26.7M | -17.6M | 13.8M |
| Other Income / Gains | -12.7M | -79.8M | -14.8M | 37.7M | 4.2M | 16.8M | -6.6M | 79K |
| Net Income | -39.2M | -92.6M | -35.9M | 15.9M | -17.7M | -10.3M | -24.2M | 13.8M |
| EPS (Diluted) | -1.46 | -3.56 | -1.38 | 0.61 | -0.68 | -0.069 | -1.13 | 0.58 |
| Reported Currency | USD | USD | USD | USD | USD | USD | USD | USD |
| Gross Profit Ratio | 1.00 | 1.00 | -27.312 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| General And Administrative Expenses | 7.1M | 8.2M | 6.6M | 7.2M | 8.3M | 7.1M | 6.6M | 7.0M |
| Selling And Marketing Expenses | 0 | 0 | 1.1M | 0 | 0 | 0 | 0 | 0 |
| Selling General And Administrative Expenses | 7.1M | 8.2M | 7.7M | 7.2M | 8.3M | 7.1M | 6.6M | 7.0M |
| Other Expenses | 0 | 0 | -12.8M | 0 | 0 | 7.6M | 0 | 0 |
| Cost And Expenses | 26.6M | 22.9M | 21.5M | 22.1M | 23.0M | 26.0M | 18.0M | 19.7M |
| Interest Income | 1.0M | 1.3M | 1.5M | 1.7M | 2.0M | 7.4M | 2.6M | 1.2M |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation And Amortization | 0 | 0 | 606K | 589K | 1.2M | 486K | 286K | 196K |
| Ebitda | -26.5M | -21.9M | -35.3M | 16.5M | -20.7M | -9.5M | -23.9M | 14.0M |
| Ebitdaratio | -339.731 | -23.167 | -78.088 | 55.285 | -18.848 | 12.49 | -61.749 | 0.417 |
| Operating Income Ratio | -339.731 | -23.167 | -46.606 | -73.191 | -19.899 | 35.219 | -45.413 | 0.411 |
| Income Before Tax | -39.2M | -101.8M | -35.9M | 15.9M | -17.7M | -10.0M | -24.2M | 13.8M |
| Income Before Tax Ratio | -502.333 | -107.465 | -79.429 | 53.309 | -16.10 | 13.13 | -62.488 | 0.414 |
| Income Tax Expense | 0 | -9.2M | 0 | 0 | 0 | 287K | 0 | 0 |
| Net Income Ratio | -502.333 | -97.757 | -79.429 | 53.309 | -16.10 | 13.509 | -62.488 | 0.414 |
| Epsdiluted | -1.46 | -3.46 | -1.38 | 0.60 | -0.68 | -0.069 | -1.13 | 0.54 |
| Weighted Average Shs Out | 26.9M | 26.0M | 26.0M | 26.0M | 25.9M | 25.9M | 21.5M | 16.7M |
| Weighted Average Shs Out Dil | 26.9M | 26.0M | 26.0M | 26.4M | 25.9M | 25.9M | 21.5M | 17.8M |